EQUIP FT
EQUIP FT
Viðurkennt
- Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated
- Clostridium perfringens, type C, beta toxoid
- Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated
- Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated
Auðkenning lyfsins
Upplýsingar um lyfið
Lyfjaform:
-
Stungulyf, dreifa
Withdrawal period by route of administration:
-
Til notkunar í vöðva
- Hestur
-
Mjólk0dagar
-
Kjöt og innmatur0dagar
-
ATC flokkun (dýralyf):
- QI05AL01
Staða markaðsleyfis:
-
Gilt
Authorised in:
-
Holland
Viðbótarupplýsingar
Entitlement type:
-
Marketing Authorisation
Markaðsleyfishafi:
- Zoetis B.V.
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
- Zoetis Belgium
Ábyrgt yfirvald:
- Medicines Evaluation Board
Markaðsleyfisnúmer:
- REG NL 10060
Dagsetning leyfisbreytingar:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Hversu gagnlegt var þessi síða?: